The effect of Riluzole on negative symptoms in patients with chronic schizophrenia: a double blind and placebo controlled trial.
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2015
At a glance
- Drugs Riluzole (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- 18 Sep 2015 Status changed from active, no longer recruiting to completed.
- 04 Jul 2012 Planned end date changed from 23 Sep 2013 to 23 Jun 2012 as reported by Iranian Registry of Clinical Trials.
- 04 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by Iranian Registry of Clinical Trials.